These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 5897927)
1. [The thyroid hormone as complementary treatment in genital and mammary cancer]. da Silveira JC Rev Ginecol Obstet (Sao Paulo); 1965 Jun; 116(6):287-93. PubMed ID: 5897927 [No Abstract] [Full Text] [Related]
2. [Progestational hormones in the pathogenesis, prophylaxis, and therapy of mammary and genital tumours]. Kaiser R Rev Fr Gynecol Obstet; 1973 Oct; 68(10):549-53. PubMed ID: 17474211 [TBL] [Abstract][Full Text] [Related]
3. [Synthetic progestatives in the treatment of hormono-dependent cancers in gynecology]. Albeaux-Fernet M; Bellot L; Canet L; Deribreux J; Gelinet M Annee Endocrinol; 1970; 22():141-51. PubMed ID: 5485064 [No Abstract] [Full Text] [Related]
6. Proceedings of the symposium, Monoclonal antibodies in gynecologic oncology. Eur J Obstet Gynecol Reprod Biol; 1985 Jun; 19(6):339-64. PubMed ID: 4018371 [No Abstract] [Full Text] [Related]
7. [Chemotherapy during pregnancy: when and how? Particulars in gynecologic and breast cancers]. Giacalone PL; Bénos P; Charlier C; Laffargue F J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3 Suppl):197-200. PubMed ID: 9471460 [No Abstract] [Full Text] [Related]
8. Overview of currently used chemosensitivity test systems in gynecologic malignancies and breast cancer. Köchli OR; Sevin BU; Averette HE; Haller U Contrib Gynecol Obstet; 1994; 19():12-23. PubMed ID: 7995043 [No Abstract] [Full Text] [Related]
9. [Thyroid hormone as a prophylactic remedy in the metastasis of mammary and genital cancer in women]. LOESER AA An R Acad Nac Med (Madr); 1955; 72(3):331-43. PubMed ID: 13302800 [No Abstract] [Full Text] [Related]
10. The fluorescent cytoprint assay in gynecological malignancies and breast cancer. Methodology and results. Blackman KE; Fingert HJ; Fuller AF; Meitner PA Contrib Gynecol Obstet; 1994; 19():53-63. PubMed ID: 7995053 [No Abstract] [Full Text] [Related]
12. Suppressive therapy after surgical treatment of thyroid gland cancer in patients with mastopathy. Makaridze T; Mardaleishvili K Georgian Med News; 2007; (148-149):17-20. PubMed ID: 17921536 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of new drugs and combinations in gynecologic tumors and cancer cell lines with the ATP-cell viability assay. Untch M; Sevin BU Contrib Gynecol Obstet; 1994; 19():145-55. PubMed ID: 7995046 [No Abstract] [Full Text] [Related]
14. [High-dose methylprednisolone in the treatment of terminal cancer patients]. Beaufort F; Lammer J; Stammberger H Wien Klin Wochenschr; 1984 Jul; 96(14):549-51. PubMed ID: 6540930 [TBL] [Abstract][Full Text] [Related]
16. Cancer in pregnancy. Falkenberry SS Surg Oncol Clin N Am; 1998 Apr; 7(2):375-97. PubMed ID: 9537983 [TBL] [Abstract][Full Text] [Related]
17. Pregnancy following operative and complementary treatment of thyroid cancer. Pomorski L; Bartos M; Narebski J Zentralbl Gynakol; 2000; 122(7):383-6. PubMed ID: 10951709 [TBL] [Abstract][Full Text] [Related]
18. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. Navo MA; Phan J; Vaughan C; Palmer JL; Michaud L; Jones KL; Bodurka DC; Basen-Engquist K; Hortobagyi GN; Kavanagh JJ; Smith JA J Clin Oncol; 2004 Feb; 22(4):671-7. PubMed ID: 14966090 [TBL] [Abstract][Full Text] [Related]
19. [The hormonal influence in gynecologic oncology]. Uyttenbroeck F Verh K Acad Geneeskd Belg; 1981; 43(1):14-46. PubMed ID: 7293393 [No Abstract] [Full Text] [Related]